Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: | Admed Levetiracetam |
Active Ingredient: | Levetiracetam 250mg |
Dosage Form: | Film coated tablet |
New Zealand Sponsor: | AdiraMedica Pty Limited |
Manufacturer: | Cipro Pharmaceuticals, Hyderabad, India |
Product: | Admed Levetiracetam |
Active Ingredient: | Levetiracetam 500mg |
Dosage Form: | Film coated tablet |
New Zealand Sponsor: | AdiraMedica Pty Limited |
Manufacturer: | Cipro Pharmaceuticals, Hyderabad, India |
Product: | Admed Levetiracetam |
Active Ingredient: | Levetiracetam 750mg |
Dosage Form: | Film coated tablet |
New Zealand Sponsor: | AdiraMedica Pty Limited |
Manufacturer: | Cipro Pharmaceuticals, Hyderabad, India |
Product: | Admed Levetiracetam |
Active Ingredient: | Levetiracetam 1000mg |
Dosage Form: | Film coated tablet |
New Zealand Sponsor: | AdiraMedica Pty Limited |
Manufacturer: | Cipro Pharmaceuticals, Hyderabad, India |
Dated this 23rd day of July 2021.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).